跳至主要内容
临床试验/NCT01897792
NCT01897792终止2 期

Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
11
试验地点
1
主要终点
Number of Total Blood Product Transfusions

研究概览

简要总结

The purpose of this study is to determine the effect of antioxidant vitamins (vitamins C and E) on the development of coagulation derangements and nosocomial pneumonia after severe trauma in patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult trauma patients admitted to the emergency department at the University of Alabama at Birmingham (UAB) Hospital
  • Blunt or penetrating injury
  • UAB highest trauma activation

排除标准

  • Age < 19 years of age
  • Patients with known bleeding diathesis or who are concurrently taking anticoagulant medication
  • Patients with known liver disease
  • Minor patients
  • Pregnant patients (known or suspected pregnancy)
  • Patients who are incarcerated
  • Patients who lack a surrogate

研究组 & 干预措施

Vitamins C and E

Experimental

Vitamin C (1,000 mg i.v.) and Vitamin E (1,000 IU p.o. via the naso-gastric tube) administered every 8 hours starting within one hour after admission to the Emergency department for up to 5 days or until discharge from the ICU, whichever comes first.

干预措施: Vitamin C (Dietary Supplement)

Vitamins C and E

Experimental

Vitamin C (1,000 mg i.v.) and Vitamin E (1,000 IU p.o. via the naso-gastric tube) administered every 8 hours starting within one hour after admission to the Emergency department for up to 5 days or until discharge from the ICU, whichever comes first.

干预措施: Vitamin E (Dietary Supplement)

0.9% saline and sugar pill

Placebo Comparator

100 ml of 0.9% saline (for i.v. Vitamin C) and a p.o. placebo (sugar pill for the p.o. Vitamin E) administered every 8 hours starting within one hour after admission to the Emergency department for up to 5 days or until discharge from the ICU, whichever comes first.

干预措施: Saline (for Vitamin C) (Dietary Supplement)

0.9% saline and sugar pill

Placebo Comparator

100 ml of 0.9% saline (for i.v. Vitamin C) and a p.o. placebo (sugar pill for the p.o. Vitamin E) administered every 8 hours starting within one hour after admission to the Emergency department for up to 5 days or until discharge from the ICU, whichever comes first.

干预措施: Placebo (for Vitamin E) (Drug)

结局指标

主要结局

Number of Total Blood Product Transfusions

时间窗: From enrollment to 3 days

the number of blood product transfusions for all subjects in each group over the course of 3 days.

Number of Subjects With Ventilator-associated Pneumonia.

时间窗: From enrollment to 3 days

Number of subjects diagnosed with pneumonia and requiring ventilator support.

Number of Participants With Coagulation Abnormalities

时间窗: From enrollment up to 3 days

Coagulation parameters are evaluated using standard functional tests (prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen and platelet count)and point of care functional analysis using thromboelastogram (TEG-ROTEM). A blood sample is collected upon arrival in the emergency department at 0 hours only and analyzed for markers of activation of coagulation, inflammation, and levels of vitamin C/E.

Number of Subjects With Organ Injury

时间窗: From enrollment to 3 days

Any injury to internal organs (thoracic, abdominal or cranial cavity)

次要结局

  • Mean Number of Days in ICU.(from enrollment up to 60 days post enrollment)
  • Number of Subjects With 60-day Survival(from enrollment up to 60 days post enrollment)
  • Number of Protocol Violations Per Arm.(from enrollment up to 60 days post enrollment)
  • Mean Number of Ventilator-free Days for Subjects(from enrollment up to 60 days post enrollment)
  • Mean Number of Hospital Stay Days.(from enrollment up to 60 days post enrollment)
  • Number of Subjects Surviving to Day 28(from enrollment up to 28 days post enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean-Francois Pittet

Principal Investigator

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验